## **Trustees’ Annual Report for the period** 

## **From        01/01/2024       Period start date   To     31/12/2024      Period end date** 

**Charity name:** The British Uro-Oncology Group 

## **Charity registration number: 1116828** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The relief of sickness of persons suffering<br>from urological cancers and the<br>advancement of education for the benefit of<br>the public concerning its identification,<br>diagnosis and treatment.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|1. Annual Educational Meeting<br>2. Website with educational resources<br>3. Uro-oncology & skills-based<br>educational meetings<br>4. Dissemination of information|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|The BUG trustees have had regard to the<br>guidance issued by the Charity<br>Commission on public benefit.|



**Additional information (optional)** You may choose to include further statements where relevant about: 

||SORP reference|
|---|---|
|Policy on grant making|Para 1.38|
|Policy on social investment|Para 1.38|
|including program related||
|investment||
|Contribution made by|Para 1.38|
|volunteers||
|Other||





## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|21st Annual Educational Meeting; held at<br>Europa Hotel, Belfast BT2 7AP on 6-7<br>September 2024, attended by over 105<br>delegates.<br>BUG meeting for Trainees in Uro-oncology<br>- Advancing skills for the future of Uro-<br>oncology; held at Thistle Hotel Marble Arch,<br>London W1H 7EH on 1-2 November 2024,<br>attended by over 40 delegates.<br>BUG website (www.bug.uk.com) running<br>with educational resources.<br>Stakeholder<br>for<br>NICE,<br>and<br>detailed<br>contributions to NICE technology appraisals<br>& nomination of experts for attendance at<br>meetings.|
|**Additional information (optional)**<br>You may choose to include further statements||where relevant about:|
|Achievements against<br>objectives set|Para 1.41||
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|Investment performance<br>against objectives|Para 1.41||





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|Details of Income and Expenditure are given<br>on the Statement of Financial Activities<br>within<br>the<br>financial<br>statements.<br>Total<br>incoming resources decreased by £65,986<br>to<br>£230,900<br>(2023:<br>£296,886).<br>The<br>allocation of the charity's expenditure<br>decreased by £117,775 to £223,830 from<br>the previous year (2023: £341,605). The<br>total unrestricted funds as at 31 December<br>2024<br>amounted<br>to<br>£137,893<br>(2023:<br>£130,823).|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|Fund future projects|
|Amount of reserves held|Para 1.22|The trustees consider that given the nature<br>of the work of the charity and assuming that<br>the charity's activities continue at the current<br>levels, this should equate to approximately<br>six months of the resources expended,<br>which<br>during<br>2024<br>amounted<br>to<br>approximately<br>£110,000.<br>This<br>should<br>provide adequate working capital for the<br>charity's core costs. The free reserves at 31<br>December 2024 are £137,893 (2023:<br>£130,823) and the trustees are satisfied that<br>this level of reserves is sufficient to meet the<br>needs of the charity.|
|Reasons for holding zero<br>reserves|Para 1.22|Not applicable|
|Details of fund materially in<br>deficit|Para 1.24|None|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|There are no uncertainties about the charity<br>continuing as a going concern.|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

||||
|---|---|---|
|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47||
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|A description of the principal<br>risks facing the charity|Para 1.46||





Other 

## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|Constitution|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|Unincorporated Association|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Election by BUG members at Annual<br>General Meeting|



**Additional information (optional)** You may choose to include further statements where relevant about: 

||||
|---|---|---|
|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51||
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51||
|Relationship with any related<br>parties|Para 1.51||
|Other|||





## **Reference and Administrative details** 

|Charity name|The British Uro-Oncology Group|
|---|---|
|Other name the charity uses|BUG|
|Registered charity number|1116828|
|Charity’s principal address|Profile Productions Ltd<br>Suite 213 Boundary House<br>Boston Road<br>London<br>W7 2QE|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>9<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body)**<br>**entitled to appoint trustee (if**<br>**any)**|
|---|---|---|---|---|
||Prof Robert<br>Huddart|Education Secretary|||
||Dr Simon Hughes||||
||Prof Amit Bahl|Chair|||
||Prof Alison Birtle|Secretary|||
||Prof Mark<br>Beresford||||
||Dr Catherine Heath||Until 7 September 2024||
||Prof Anne Kiltie||||
||Dr Rhona<br>McMenemin||||
||Dr Carys Thomas||||
||Dr Alex Martin||||
||Prof Rob Jones||||
||Dr Julia Murray||||
||Prof Ananya<br>Choudhury||||
||Prof Joseph<br>O’Sullivan|Treasurer|||
||Dr Amarnath<br>Challapalli||||
||Professor Simon<br>Crabb||||
||Dr Anita Mitra||From 7 September 2024||
||Prof Isabel<br>Syndikus||From 7 September 2024||
||Prof Balaji<br>Venugopal||From 7 September 2024||



– Corporate trustees names of the directors at the date the report was approved 

**Director name** 

Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets Not applicable held in this capacity Name and objects of the Not applicable charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|
|---|---|---|
|**Type of**<br>**adviser**<br>**Name**<br>**Address**|||
||||
||||
||||
||||
|**Name of chief executive or names of senior staff members (Optional information)**|||
||||



## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

Not applicable 

## **Other optional information** 

None 



Declarations
Th• tru8to•8 declare that they have approved the tru8to••' report above.
Slgned on behalf of tho
arlty's
st
Slgnature(
Full name(s
Poslllon (eg Secretary,
Chalr, etc)
O'sullivan
Treasurer
Date
29.09.2025

|Charity No<br>(if any)<br>1116828<br>Period start date<br>01-Jan-24<br>**To**<br>Period end<br>date<br>31-Dec-24<br>Charity Name: The British Uro-Oncology Group<br>Annual accounts for theperiod<br>—~~———— ——~~<br>FOR ENGLAND AND WALES|Charity No<br>(if any)<br>1116828<br>Period start date<br>01-Jan-24<br>**To**<br>Period end<br>date<br>31-Dec-24<br>Charity Name: The British Uro-Oncology Group<br>Annual accounts for theperiod<br>—~~———— ——~~<br>FOR ENGLAND AND WALES|Charity No<br>(if any)<br>1116828<br>Period start date<br>01-Jan-24<br>**To**<br>Period end<br>date<br>31-Dec-24<br>Charity Name: The British Uro-Oncology Group<br>Annual accounts for theperiod<br>—~~———— ——~~<br>FOR ENGLAND AND WALES|Charity No<br>(if any)<br>1116828<br>Period start date<br>01-Jan-24<br>**To**<br>Period end<br>date<br>31-Dec-24<br>Charity Name: The British Uro-Oncology Group<br>Annual accounts for theperiod<br>—~~———— ——~~<br>FOR ENGLAND AND WALES|Charity No<br>(if any)<br>1116828<br>Period start date<br>01-Jan-24<br>**To**<br>Period end<br>date<br>31-Dec-24<br>Charity Name: The British Uro-Oncology Group<br>Annual accounts for theperiod<br>—~~———— ——~~<br>FOR ENGLAND AND WALES|Charity No<br>(if any)<br>1116828<br>Period start date<br>01-Jan-24<br>**To**<br>Period end<br>date<br>31-Dec-24<br>Charity Name: The British Uro-Oncology Group<br>Annual accounts for theperiod<br>—~~———— ——~~<br>FOR ENGLAND AND WALES||
|---|---|---|---|---|---|---|
|**Section A                      Statement of financial activities**|**Section A                      Statement of financial activities**||||||
|**Recommended categories by**<br>**activity**||Guidance Note<br>**Unrestricted**<br>**funds**|**Unrestricted**<br>**Restricted**<br>**income**<br>**funds**|**Endowment**<br>**funds**|**Total funds**|**Prior year**<br>**funds**|
|||**£**|**£**|**£**|**£**|**£**|
|**Incoming resources (Note 3)**||F01|F02|F03|F04|F05|
|**Income and endowments from:**|||||||
|Donations and legacies||S01<br>-|-|-|-|160|
|Charitable activities||S02<br>48,350|-|-|48,350|60,305|
|Other trading activities||S03<br>182,050|-|-|182,050|234,171|
|Investments||S04<br>-|-|-|-|-|
|Separate material item of income||S05<br>-|-|-|-|-|
|Other income||S06<br>500|-|-|500|2,250|
|**_Total_**||S07<br>230,900|-|-|230,900|296,886|
|**Resources expended (Note 6)**|||||||
|**Expenditure on:**|||||||
|Raising funds||S08<br>770|-|-|770|3,680|
|Charitable activities||S09<br>223,060|-|-|223,060|337,925|
|Separate material item of expense||S10|||||
|Other||S11<br>-|-|-|-|-|
|**_Total_**||S12<br>223,830|-|-|223,830|341,605|
||||||||
|**Net income/(expenditure) before investment**|||||||
|**gains/(losses)**||S13<br>7,070|-|-|7,070|(44,719)|
|Net gains/(losses) on investments||S14<br>-|-|-|-|-|
|**Net income/(expenditure)**||S15<br>7,070|-|-|7,070|(44,719)|
|**Extraordinary items**||S16<br>-|-|-|-||
|**Transfers between funds**||S17<br>-|-|-|-|-|
|**Other recognised** **gains/(losses):**|||||||
|Gains and losses on revaluation of fixed assets for the charity’s own use||S18<br>-<br>Gains and losses on revaluation of fixed assets for the charity’s own use|-|-|-|-|
|Other gains/(losses)||S19<br>-|-|-|-|-|
|**_Net movement in funds_**||S20<br>7,070|-|-|7,070|(44,719)|
|**_Reconciliation of funds:_**|||||||
|Total funds brought forward||S21<br>130,823|-|-|130,823|175,542|
|**_Total funds carried forward_**||S22<br>137,893|-|-|137,893|130,823|





## RG:pA **Section B** MOSS **. Balance sheet** Tee 

||fl|||**Restricted**|**Restricted**||||||
|---|---|---|---|---|---|---|---|---|---|---|
||·:5|**Unrestricted**<br>**funds**|**Unrestricted**||**Income**<br>**funds**<br>**Endowment**<br>**funds**||**Total this**<br>**year**||**Total last**<br>**year**||
|||£|||£<br>£||£||||
|**Fixed assets**||F01|||F02<br>F03||F04||F05||
|**Intangible assets**<br>**Tangible assets**<br>**Heritage assets**<br>**Investments**<br>**(Note 15)**<br>**(Note 14)**<br>**(Note 16)**<br>**(Note 17)**<br>**_Total fixed assets_**|B01<br>B02<br>B03<br>B04<br>B05|[<br>«fl<br>mw)<br>rf -2f<br>= |<br>es<br>a<br>ee) es<br>a<br>Te<br>ee|<br>rs ee<br>ees<br>ee ee<br>es<br>ee|||||||||
|**Current assets**|||||||||||
|**Stocks**<br>**(Note 18)**<br>**Debtors**<br>**(Note 19)**<br>**Investments**<br>**(Note 17.4)**<br>**Cash at bank and in hand (Note 24)**<br>**_Total current assets_**|sos<br>B07<br>008<br>009<br>010|**-**<br>21,065<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>-<br>**-**<br>-<br>-<br>**-**<br>-<br>| eee ee~~s~~<br>~~—~~<br>30,906 |~~|~~<br>es<br>eS|||||-<br>21,065<br>~~**-**~~<br>1 JU,9c.f6<br>151,971<br>-<br>56,510<br>~~-~~<br>126,382<br>182,892<br>~~|~~<br>eee~~Eee~~<br>eae||||
|**Creditors: amounts falling due within**<br>**one year**<br>**(Note 20)**|011|14,078|||||14,0781||52,0691||
|**_Net current assets/(liabilities)_**|012|137,893<br>2|||- I<br>- I137,893<br>eeeeee||||130,823I|I|
|**_Total assets less current liabilities_**|**_Total assets less current liabilities_**<br>013|137,893<br>EZ|||**-** I<br>- I137,893<br>130,823 I<br>ar<br>TS|||||130,823 I|
|**Creditors: amounts falling due after**|||||||||||
|**one year**<br>**(Note 20)**|014||||||||||
|**Provisions for liabilities**|015||||||||||
|**_Total net assets or liabilities_**|816|137,893<br>- I<br>-<br>1<br>137,8931<br>130.8231<br>~~7aae~~|||||||||
|**Funds of the Charity**<br>**Endowment funds (Note 27)**<br>**Restricted income funds (Note**27)<br>**Unrestricted funds**|817<br>818<br>019|**-**<br>~~I~~137,893|||**I**~~- I~~<br>-||~~-~~<br>**-**<br>137,893||~~**-**~~<br>-<br>130,823||
|**Revaluation reserve**|020||||||-||||
|**_Total funds_**|**_Total funds_**<br>021|I137,893|||**-** I<br>-||137,893||130,823||
|Signed by one or two trustees on behalf of all<br>the trustees|FMGQAYE<br>==<br>2a||2a|2a|Print Name<br>Prof Jose h O'Sullivan<br>,<br>2a|||Date of<br>approval<br>dd/mm/<br>29.09.2025<br>~~=~~<br>Ld|||



2 

CC17a (Excel) 

10/07/2025 



## **Section C                                            Notes to the accounts** 

## Note 1 **Basis of preparation** 

_**This section should be completed by all charities** ._ 

## **1.1 Basis of accounting** 

These accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts. The accounts have been prepared in accordance with: 

the Statement of Recommended Practice: Accounting and Reporting by Charities •  and with* ✓ preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) issued on 16 July 2014 •  and with* ✓ the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) • and with the Charities Act 2011. The charity constitutes a public benefit entity as defined by ✓ FRS 102.* 

- -Tick as appropriate 

## **1.2  Going concern** 

_**If there are material uncertainties related to events or conditions that cast significant doubt on the charity's ability to continue as a going concern, please provide the following details or state "Not applicable", if appropriate:**_ 

An explanation as to those factors that _The trustees consider that there are no material uncertainties_ support the conclusion that the charity is a _about the Charity’s ability to continue as a going concern. The_ going concern; _trustees have considered a period of one year from the accounts signing date to assess the charity's ability to continue as a going concern._ Disclosure of any uncertainties that make the _Not applicable_ going concern assumption doubtful; Where accounts are not prepared on a going _Not applicable_ concern basis, please disclose this fact together with the basis on which the trustees prepared the accounts and the reason why the charity is not regarded as a going concern. 

## **1.3 Change of accounting policy** 

The accounts present a true and fair view and the accounting policies adopted are those outlined in note { 2 }. 

Yes* ✓ * -Tick as appropriate No* 

## _**Please disclose:**_ 

|**_Please disclose:_**||
|---|---|
|**_(i) the nature of the change in accounting policy;_**|_Not applicable_|
|**_(ii) the reasons why applying the new accounting policy_**<br>**_provides more reliable and more relevant information;_**<br>**_and_**|_Not applicable_|
|**_(iii) the amount of the adjustment for each line affected_**<br>**_in the current period, each prior period presented and_**<br>**_the aggregate amount of the adjustment relating to_**<br>**_periods before those presented, 3.44 FRS 102 SORP._**|_Not applicable_|



## **1.4 Changes to accounting estimates** 

No changes to accounting estimates have occurred in the reporting period (3.46 FRS 102 SORP). Yes* ✓ * -Tick as appropriate No* 

## _**Please disclose:**_ 

|**_Please disclose:_**||
|---|---|
|**_(i) the nature of any changes;_**|_Not applicable_|
|**_(ii) the effect of the change on income and expense or_**<br>**_assets and liabilities for the current period; and_**|_Not applicable_|
|**_(iii) where practicable, the effect of the change in one or_**<br>**_more future periods._**|_Not applicable_|



## **1.5 Material prior year errors** 

No material prior year error have been identified in the reporting period (3.47 FRS 102 SORP). 

Yes* ✓ * -Tick as appropriate No* _**Please disclose:** Not applicable_ _**(i) the nature of the prior period error; (ii) for each prior period presented in the accounts, the** Not applicable_ _**amount of the correction for each account line item affected; and (iii) the amount of the correction at the beginning of the** Not applicable_ _**earliest prior period presented in the accounts.**_ 

CC17a (Excel) 

10/07/2025 

3 



## **Section C                                            Notes to the accounts** 

## **Note 2                           Accounting policies** 

_Please complete this note when first reporting under FRS2102.  Section 35 of FRS102, requires 3 reconciliations to be presented, if all are applicable._ 


**----- Start of picture text -----**<br>
2.1 RECONCILIATION WITH PREVIOUS GENERALLY ACCEPTED ACCOUNTING<br>PRACTICE<br>Please provide a description<br>of the nature of each change  No changes in accounting policy<br>in accounting policy<br>Reconcilation of funds per previous GAAP to funds determined under FRS 102<br>Start of  End of<br>period period<br>£ £<br>Fund balances as previously<br>stated<br>Adjustments:<br>Fund balance as restated<br>Reconcilation of net income/(net expenditure) per previous GAAP to net income/(net expenditure) under FRS 102<br>End of<br>£<br>Net income/(expenditure) as previously<br>stated<br>Adjustments:<br>Previous period net income/(expenditure) as<br>restated<br>**----- End of picture text -----**<br>


CC17a (Excel) 

10/07/2025 

4 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 2                           Accounting policies 2.2 INCOME** 

|**Note 2                           Accounting policies**<br>**2.2 INCOME**||||
|---|---|---|---|
|_This standard list of accounting policies has been applied by the charity except for those ticked "No" or "N/a".  Where a_<br>_different or additional policy has been adopted then this is detailed in the box below._|Yes<br>No<br>N/a|||
|**Recognition of income**<br>**Offsetting**<br>**Grants and donations**<br>**Donated goods**<br>**Volunteer help**<br>This is included in the accounts when receipt is probable and the amount receivable can<br>be measured reliably.<br>Donated services and facilities that are consumed immediately are recognised as income<br>with an equivalent amount recognised as an expense under the appropriate heading in<br>the SOFA.<br>**Tax reclaims on**<br>**donations and gifts**<br>Donated goods are measured at fair value (the amount for which the asset could be<br>exchanged) unless impractical to do so.<br>Gifts in kind for use by the charity are included in the SoFA as income from donations<br>when receivable.<br>Donated services and facilities are included in the SOFA when received at the value of<br>the gift to the charity provided the value of the gift can be measured reliably.<br>Membership subscriptions which gives a member the right to buy services or other<br>benefits are recognised as income earned from the provision of goods and services as<br>income from charitable activities.<br>Membership subscriptions received in the nature of a gift are recognised in Donations<br>and Legacies.<br>The value of any voluntary help received is not included in the accounts but is described<br>in the trustees’ annual report.<br>**Support costs**<br>The charity has incurred expenditure on support costs.<br>**Income from membership**<br>**subscriptions**<br>**Income from interest,**<br>**royalties and dividends**<br>In the case of performance related grants, income must only be recognised to the extent<br>that the charity has provided the specified goods or services as entitlement to the grant<br>only occurs when the performance related conditions are met (5.16 FRS 102 SORP).<br>**Government grants**<br>The charity has received government grants in the reporting period<br>**Legacies**<br>Grants and donations are only included in the SoFA when the general income recognition<br>criteria are met (5.10 to 5.12 FRS 102 SORP).<br>Legacies are included in the SOFA when receipt is probable, that is, when there has<br>been grant of probate, the executors have established that there are sufficient assets in<br>the estate and any conditions attached to the legacy are either within the control of the<br>charity or have been met.<br>Gift Aid receivable is included in income when there is a valid declaration from the donor.<br>Any Gift Aid amount recovered on a donation is considered to be part of that gift and is<br>treated as an addition to the same fund as the initial donation unless the donor or the<br>terms of the appeal have specified otherwise.<br>These are included in the Statement of Financial Activities (SoFA) when:<br>• the charity becomes entitled to the resources;<br>·       it is more likely than not that the trustees will receive the resources; and<br>• the monetary value can be measured with sufficient reliability.<br>There has been no offsetting of assets and liabilities, or income and expenses, unless required or<br>permitted by the FRS 102 SORP or FRS 102.<br>**Contractual income and**<br>**performance related**<br>**grants**<br>This is only included in the SoFA once the charity has provided the related goods or<br>services or met the performance related conditions.<br>The cost of any stock of goods donated for distribution to beneficiaries is deemed to be<br>the fair value of those gifts at the time of their receipt and they are recognised on receipt.<br>In the reporting period in which the stocks are distributed, they are recognised as an<br>expense at the carrying amount of the stocks at distribution.<br>Donated goods for resale are measured at fair value on initial recognition, which is the<br>expected proceeds from sale less the expected costs of sale, and recognised in 'Income<br>from other trading activities' with the corresponding stock recognised in the balance<br>sheet.  On its sale the value of stock is charged against 'Income from other trading<br>activities' and the proceeds from  sale are also recognised as 'Income from other trading<br>activities'.<br>Goods donated for on-going use by the charity are recognised as tangible fixed assets<br>and included in the SoFA as incoming resources when receivable.<br>**Donated services and**<br>**facilities**||||
||✓|||
||Yes<br>No<br>N/a<br>|||
||✓|||
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||✓|||
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|
||Yes<br>No<br>N/a|||
||✓|||





|**Grants with performance**<br>**conditions**<br>**2.4 ASSETS**<br>**Heritage assets**<br>**Liability recognition**<br>Liabilities are recognised where it is more likely than not that there is a legal or<br>constructive obligation committing the charity to pay out resources and the amount of the<br>obligation can be measured with reasonable certainty.<br>The charity has heritage assets, that is, non-monetary assets with historic, artistic,<br>scientific, technological, geophysical or environmental qualities that are held  and<br>maintained principally for their contribution to knowledge and culture.  The depreciation<br>rates and methods used as disclosed in note 16.<br>They are valued at cost.<br>The charity has intangible fixed assets, that is, non-monetary assets that do not have<br>physical substance but are identifiable and are controlled by the charity through custody<br>or legal rights.  The amortisation rates and methods used are disclosed in note 15<br>Insurance claims are only included in the SoFA when the general income recognition<br>criteria are met (5.10 to 5.12 FRS 102 SORP) and are included as an item of other<br>income in the SoFA.<br>**Deferred income**<br>Material items of deferred income have been included in the accounts.<br>**Provisions for liabilities**<br>A liability is measured on recognition at its historical cost and then subsequently<br>measured at the best estimate of the amount required to settle the obligation at the<br>reporting date<br>**Basic financial**<br>**instruments**<br>The charity accounts for basic financial instruments on initial recognition as per<br>paragraph 10.7 FRS 102 SORP.  Subsequent measurement is as per paragraphs 11.17<br>to 11.19, FRS 102 SORP.<br>**Stocks and work in**<br>**progress**<br>Stocks held for sale as part of non-charitable trade are measured at the lower or cost or n<br>realisable value.<br>Goods or services provided as part of a charitable activity are measured at net realisable<br>based on the service potential provided by items of stock.<br>**Tangible fixed assets for**<br>**use by charity**<br>The depreciation rates and methods used are disclosed in note 14.<br>**Intangible fixed assets**<br>Fixed asset investments in quoted shares, traded bonds and similar investments are<br>valued at initially at cost  and subsequently at fair value (their market value) at the year<br>end.  The same treatment is applied to unlisted investments unless fair value cannot be<br>measured reliably in which case it is measured at cost less impairment.<br>**Investments**<br>**2.3 EXPENDITURE AND LIABILITIES**<br>Where the charity gives a grant with conditions for its payment being a specific level of<br>service or output to be provided, such grants are only recognised in the SoFA once the<br>recipient of the grant has provided the specified service or output.<br>**Grants payable without**<br>**performance conditions**<br>The charity has creditors which are measured at settlement amounts less any trade<br>discounts<br>**Redundancy cost**<br>The charity made no redundancy payments during the reporting period.<br>**Creditors**<br>**Governance  and support**<br>**costs**<br>Work in progress is valued at cost less any foreseeable loss that is likely to occur on the c<br>**Settlement of insurance**<br>**claims**<br>**Investment gains and**<br>**losses**<br>This includes any realised or unrealised gains or losses on the sale of investments and<br>any gain or loss resulting from revaluing investments to market value at the end of the<br>year.<br>Support costs have been allocated between governance costs and other support.<br>Governance costs comprise all costs involving public accountability of the charity and its<br>compliance with regulation and good practice.<br>Support costs include central functions and have been allocated to activity cost<br>categories on a basis consistent with the use of resources, eg allocating property costs<br>by floor areas, or per capita, staff costs by the time spent and other costs by their usage.<br>Where there are no conditions attaching to the grant that enables the donor charity to<br>realistically avoid the commitment, a liability for the full funding obligation must be<br>recognised.<br>They are valued at cost.<br>These are capitalised if they can be used for more than one year, and cost at least<br>They are valued at cost.<br>Investments held for resale or pending their sale and cash and cash equivalents with a<br>maturity date of less than 1 year are treated as current asset investments||Yes<br>No<br>N/a|Yes<br>No<br>N/a|Yes<br>No<br>N/a|
|---|---|---|---|---|
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||✓|||
|||Yes<br>No<br>N/a|||
|||✓|||
|||Yes<br>No<br>N/a|||
|||✓|||
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||✓|||
|||Yes<br>No<br>N/a|||
|||✓|||
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||✓|||
||||||
|||Yes<br>No<br>N/a|||
|||||✓|
||et<br>value<br>ontract.|Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|
|||Yes<br>No<br>N/a|||
|||||✓|





|They are valued at fair value except where they qualify as basic financial instruments.<br>The charity has has investments which it holds for resale or pending their sale and cash and cash<br>equivalents with a maturity date less than one year. These include cash on deposit and cash<br>equivalents with a maturity date of less than one year held for investment purposes rather than to<br>meet short term cash commitments as they fall due.<br>**Debtors**<br>Debtors (including trade debtors and loans receivable) are measured on initial recognition at<br>settlement amount after any trade discounts or amount advanced by the charity.  Subsequently,<br>they are measured at the cash or other consideration expected to be received.<br>**Current asset investments**|Yes<br>No<br>N/a|Yes<br>No<br>N/a|Yes<br>No<br>N/a|
|---|---|---|---|
||✓|||
||Yes<br>No<br>N/a<br>|||
||||✓|
||Yes<br>No<br>N/a|||
||||✓|



**POLICIES ADOPTED ADDITIONAL TO OR None DIFFERENT FROM THOSE ABOVE** 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 3                           Analysis of income** 

|**Other informati**<br> <br>**Donations**<br>**and legacies:**<br>**Charitable**<br>**activities:**<br>**TOTAL INCO**<br>**Other:**<br>**Other trading**<br>**activities:**<br>**Income from**<br>**investments:**<br>**Separate**<br>**material item**<br>**of income:**|<br>**Analysis**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|
|---|---|---|---|---|---|---|
||Donations|-|-|-|-|160|
||Gift Aid|-|-|-|-|-|
||Legacies|-|-|-|-|-|
||General grants|-|-|-|-|-|
||<br>Membership subscriptions and sponsorships<br>which are in substance donations|-|-|-|-||
||Donated goods, facilities and  services|-|-|-|-|-|
||<br>Other|-|-|-|-||
||**Total**|-|-|-|-|160|
||||||||
||Annual meetingincome|35,700|-|-|35,700|47,015|
||Subscriptions|12,650|-|-|12,650|13,290|
||Other|-|-|-|-|-|
||**Total**||||||
|||48,350|-|-|48,350|60,305|
||||||||
||Sponsorship<br>|182,050|-|-|182,050|234,171|
|||-|-|-|-|-|
|||-|-|-|-|-|
||Other|-|-|-|-|-|
||**Total**|182,050|-|-|182,050|234,171|
||||||||
||Interest income|-|-|-|-|-|
||Dividend income|-|-|-|-|-|
||Rental and leasing income|-|-|-|-|-|
||<br>Other|-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
||Conversion of endowment funds into income|-|-|-|-|-|
||Gain on disposal of a tangible fixed asset held<br>for charity's own use|<br> -|-|-|-|-|
||<br>Gain on disposal of a programme related<br>investment|-|-|-|-|-|
||Royalties from the exploitation of intellectual<br>property rights|-|-|-|-|-|
||<br>Other income|500|-|-|500|2,250|
||**Total**|500|-|-|500|2,250|
||**on:**<br>**ME**||||||
|||230,900|-|-|230,900|296,886|
||||||||
|**All income in the prior year was unrestricted except for:**<br>**(please provide description and amounts)**||Not applicable|||||
|**Where any endowment fund is converted into income in the**<br>**reporting period, please give the reason for the conversion.**|||||||
|||Not applicable|||||
||||||||
|**Within the income items above the following items are**<br>**material: (please disclose the nature, amount and any prior**<br>**year amounts)**||Noted above.|||||



CC17a (Excel) 

10/07/2025 

8 



**Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 4                           Analysis of receipts of government grants** 

|**Government grant 1**<br>**Government grant 2**<br>**Government grant 3**<br>**Other**<br>**_Please provide details of any_**<br>**_unfulfilled conditions and other_**<br>**_contingencies attaching to grants_**<br>**_that have been recognised in income._**|**This year**<br>**Last year**<br>**£**<br>**£**<br>**Description**|**This year**<br>**Last year**<br>**£**<br>**£**<br>**Description**|**This year**<br>**Last year**<br>**£**<br>**£**<br>**Description**|
|---|---|---|---|
|||-|-|
|||-|-|
|||-|-|
|||-|-|
||**Total**|-|-|
|||||
|||||



_**Please give details of other forms of government assistance from which the charity has directly benefited.**_ 

CC17a (Excel) 

10/07/2025 

9 



**Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 5                           Donated goods, facilities and services** 

**Seconded staff Use of property Honorarium Please provide details of the accounting policy for the recognition and valuation of donated goods, facilities and services.** Not applicable **Please provide details of any unfulfilled conditions and other contingencies attaching to resources from donated goods and services not recognised in income.** Not applicable **Please give details of other forms of other donated goods and services not recognised in the accounts, eg contribution of unpaid volunteers.** Not applicable 

|**This year**<br>**Last year**<br>**£**<br>**£**|**This year**<br>**Last year**<br>**£**<br>**£**|
|---|---|
|-|-|
|-|-|
|-|-|
|-|-|



CC17a (Excel) 

10/07/2025 

10 



## **Section C                                            Notes to the accounts                                                (cont)** 

## **Note 6                           Analysis of expenditure** 

|**Analysis of expenditure**<br>**Other**<br>**Expenditure on raising**<br>**funds:**<br>**Expenditure on**<br>**charitable activities**<br>**Separate material item**<br>**of expense**<br>**Other information:**<br>**TOTAL EXPENDITURE**|**Analysis**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Prior year**<br>**£**<br>**£**|
|---|---|---|---|---|---|---|
||Incurred seeking donations|-|-|-|-|-|
||Incurred seeking legacies|-|-|-|-|-|
||Incurred seeking sponsorship<br>income|770|||770|3,680|
||Operating membership|||||-|
||Staging fundraising events||||||
||Fudraising agents||||||
||Operating charity shops||||||
||Operating a trading company<br>undertakingnon-charitable trading||||||
||Advertising, marketing, direct mail<br>and publicity|-|-|-|-|-|
||<br>Start up costs incurred in generating<br>new source of future income|-<br>|-|-|-|-|
||Database development costs|-|-|-|-|-|
||Other trading activities||||||
||Investment management costs:|-|-|-|-||
||Portfolio management costs|-|-|-|-|-|
||<br>Cost of obtaining investment advice|-|-|-|-|-|
||Investment administration costs|-|-|-|-|-|
||Intellectual property licencing costs|-|-|-|-|-|
||Rent collection, property repairs and<br>maintenance charges|-<br>|-|-|-|-|
|||-|-|-|-|-|
||~~**Total expenditure on raising**~~<br>**funds**|770|<br>-|-|770|3,680|
||||||||
||Annual educational meeting|167,199|-|-|167,199|238,668|
||Uro-oncology & skills based<br>educational meetings|43,203|-|-|43,203|60,425|
||Dissemination of information|12,658|-|-|12,658|38,832|
||**Total expenditure on charitable**<br>**activities**|223,060|-|-|223,060|337,925|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||**Total**|-|-|-|-|-|
||||||||
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
|||-|-|-|-|-|
||**Total other expenditure**|-|-|-|-|-|
||**on charitable activities**||||||
|||223,830|-|-|223,830|341,605|
||||||||



CC17a (Excel) 

10/07/2025 

11 



|**Activity or programme**|**Activities undertaken directly**|**Activities undertaken directly**|**Activities undertaken directly**|**Grant**<br>**funding**<br>**of**<br>**activities**|**Support**<br>**Costs**|**Total this**<br>**year**|**_Total prior_**<br>**_year_**|
|---|---|---|---|---|---|---|---|
|||**£**||**£**|**£**|**£**|**£**|
|Annual educational meeting||150,171|||17,028|167,199|238,668|
|Uro-oncology & skills based<br>educational meetings||38,927|||4,276|43,203|60,425|
|Dissemination of information||11,405|||1,253|12,658|38,832|
|||||||||
|**Total**||200,503|||22,557|223,060|337,925|
|||||||||
|**Prior year expenditure on charitable activities can be**<br>**analysed as follows:**||Noted above||||||
|||||||||
|**Within the expenditure items above the following**<br>**items are material: (please disclose the nature,**<br>**amount and any prior year amounts)**||Annual educational meeting £150,171 (2023: £220,528),  BUG Bytes £Nil<br>(2023: £11,608), BUG e-alert £2,530 (2023: £5,280), Trainees meeting<br>£38,927 (2023: £37,935), nmCPRC meeting £Nil (2023: £18,063),<br>Prehabilitation meeting £4,200 (2023: £17,890, Secretariat £12,355 (2023:<br>£10,000), Committee meetings £2,860 (2023: £7,972), Accountancy £3,220<br>(2023: £3,100),Professional fees £2,803(2023: £2,847)||||||



CC17a (Excel) 

10/07/2025 

12 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 7                   Extraordinary items** 

## _**Please explain the nature of each extraordinary item occurring in the period.**_ 

|**Description**|**This year**<br>**Last year**<br>**£**<br>**£**|**This year**<br>**Last year**<br>**£**<br>**£**|
|---|---|---|
||-|-|
||||
||-|-|
||-|-|
||-|-|
||||
||-|-|
|**s**|-|-|



**Extraordinary item 1 Extraordinary item 2 Extraordinary item 3 Extraordinary item 4 Total extrordinary items** 

CC17a (Excel) 

10/07/2025 

13 



## **Section C                                            Notes to the accounts** 

## **Note 8                   Funds received as agent** 

_**8.1   Please complete this note if the charity has agreed to administer the funds of another entity as its agent.  Note: If a charity is acting as an agent, it should not recognise the income in the Statement of Financial Activities or the Balance Sheet.**_ 

|||**Amount received**|**Amount received**|**Amountpaid out**|**Amountpaid out**|**Balance held atperiod end**|**Balance held atperiod end**|
|---|---|---|---|---|---|---|---|
|**Description/name of party**|**Related**<br>**party (Yes**<br>**or No)**|**Thisyear**|**Lastyear**|**Thisyear**|**Lastyear**|**Thisyear**|**Lastyear**|
|||**£**|**£**|**£**|**£**|**£**|**£**|
|||-|-|-|-|-|-|
|||-|-|-|-|-|-|
|||-|-|-|-|-|-|
|||-|-|-|-|-|-|
|||-|-|-|-|-|-|
|**Total**||-|-|-|-|-|-|



_**8.2   Where a consortia or similar arrangement exists whereby 2 or more charities co-operate to achieve economies in the purchase of goods or services, please discose details of any balances outstanding between any participating members.**_ 

|**Description/name of party**|**Balance held atperiod end**|**Balance held atperiod end**|
|---|---|---|
||**Thisyear**|**Lastyear**|
||**£**|**£**|
||-|-|
||-|-|
||-|-|
||-|-|
||-|-|
|**Total**|-|-|



CC17a (Excel) 

10/07/2025 

14 



## **Section C                                            Notes to the accounts** 

**Note 9                           Support Costs** _**Please complete this note if the charity has analysed its expenses using activity categories and has support costs.**_ 

|**Support cost**<br>**(examples)**|**Raising funds**<br>**£**|**Annual**<br>**educational**<br>**meeting**|**Meetings**<br>**reviewing**<br>**service delivery**<br>**for prostate**<br>**cancer**|**Dissemination**<br>**of information**|**Grand total**<br>**£**|**Basis of**<br>**allocation**|
|---|---|---|---|---|---|---|
|||**£**|**£**|**£**||**(Describe**<br>**method)**|
|Governance|-|16,547|4,276|1,253|22,076|Pro-rata|
|Paypal and bank<br>charges|-|481|-|-|481|Actual|
|Bad debts|-|-|-|-|-|Actual|
|Other|-|-||-|-||
|**Total**|-|17,028|4,276|1,253|22,557||



_**Please provide details of the accounting policy adopted for the apportionment of costs between activities and any estimation techniques used to calculate their apportionment.**_ 

The governance costs have been apportioned to the charitable activities based on a ratio applied using each charitable activity cost to the total charitable activities costs. 

CC17a (Excel) 

10/07/2025 

15 



## **Section C                                            Notes to the accounts** 

## **Note 10                           Details of certain items of expenditure** 

## **10.1 Fees for examination of the accounts** 

_**Please provide details of the amount paid for any statutory external scrutiny of accounts and other services provided by your independent examiner.  If nothing was paid please enter '0' in the appropriate box(es).**_ 

|**Other fees (for example: financial advice, consultancy, accountancy services) paid**<br>**to the independent examiner**<br> <br>**Independent examiner’s fees**<br>**Assurance services other than audit or independent examination**<br>**Tax advisory fees**|**This year**<br>**£**|**Last year**<br>**£**|
|---|---|---|
||1,300|1,250|
||||
||||
||4,723|4,697|



CC17a (Excel) 

10/07/2025 

16 



## **Section C                                            Notes to the accounts                                              (cont)** 

**Note 11                           Paid employees** _**Please complete this note if the charity has any employees.**_ 

## **11.1 Staff Costs** 

|**Salaries and wages**<br>**Social security costs**<br>**Other employee benefits**<br>**Total staff costs**<br>**Pension costs (defined contribution scheme)**|**This year**<br>**£**|**Last year**<br>**£**|
|---|---|---|
||-|-|
||-|-|
||||
||-|-|
||-|-|



**Please provide details of expenditure on staff working for the charity whose contracts are with and are paid by a related party** 

_**Please give details of the number of employees whose total employee benefits (excluding employer pension costs) fell within each band of £10,000 from £60,000 upwards.  If there are no such transactions, please enter 'true' in the box provided.**_ 

**No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000** 

|**Band**|**Number of employees**|
|---|---|
|**£60,000 to £69,999**||
|**£70,000 to £79,999**||
|**£80,000 to £89,999**||
|**£90,000 to £99,999**||
|**£100,000 to £109,999**||
|||
|||
|||



**Please provide the total amount paid to key management personnel (includes trustees and senior management) for their services to the charity** 

## **11.2 Average head count in the year** 

**The parts of the charity in which the employees work** 

||**This year**<br>**Number**|**Last year**<br>**Number**|
|---|---|---|
|**Fundraising**|-|-|
|**Charitable Activities**|-|-|
|**Governance**|-|-|
|**Other**|-|-|
|**Total**|-|-|



**11.3 Ex-gratia payments to employees and others (excluding trustees)** 

CC17a (Excel) 

10/07/2025 

17 



## _**Please complete if an ex-gratia payment is made.**_ 

**Please explain the nature of the payment** 

**Please state the legal authority or reason for making the payment** 

**Please state the amount of the payment (or value of any waiver of a right to an asset)** 

## **11.4 Redundancy payments** 

_**Please complete if any redundancy or termination payment is made in the period.**_ 

**Total amount of payment** 

**The nature of the payment (cash, asset etc.)** 

**The extent of redundancy funding at the balance sheet date** 

**Please state the accounting policy for any redundancy or termination payments** 

CC17a (Excel) 

10/07/2025 

18 



## **Section C                                            Notes to the accounts                                                        (cont)** 

**Note 12                       Defined contribution pension scheme or defined benefit scheme accounted for as a defined contribution scheme.** 

## _**12.1   Please complete this note if a defined contribution pension scheme is operated.**_ 

**Amount of contributions recognised in the SOFA as an expense Please explain the basis for allocating the liability and expense of defined contribution pension scheme between activities and between restricted and unrestricted funds.** 

_**12.2  Please complete this section where the charity participates in a defined benefit pension plan but is unable to ascertain its share of the underlying assets and liabilities.**_ 

**Please confirm that altough the scheme is accounted for as a defined contribution plan, it is a defined benefit plan. Please provide such information as is available about the plan's surplus or deficit and the implications, if any, for the reporting charity** 

_**12.3  Please complete this section where the charity participates in a multi-employer defined benefit pension plan that is accounted for as a defined contribution plan.**_ 

**Describe the extent to which the charity can be liable to the plan for other entities' obligations under the terms and conditions of the multi-employer plan** 

CC17a (Excel) 

10/07/2025 

19 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 13                           Grantmaking** 

_**Please complete this note if the charity made any grants or donations which in aggregate form a material part of the charitable activities undertaken.**_ 

## **13.1 Analysis of grants paid (included in cost of charitable activities)** 

||||||
|---|---|---|---|---|
|**Analysis**|~~**Grants to**~~<br>**institutions**|~~**Grants to**~~<br>**individuals**|**Support costs**|**Total**|
|Activityorproject 1|||**£**|**£**|
|Activityorproject 2|||-|-|
|Activityorproject 3|||-|-|
|Activityorproject 4|||-|-|
|**_Total_**|**-**|**-**|**-**|**-**|



## _**Please enter “Nil” if the charity does not identify and/or allocate support costs.**_ 

## **13.2 Grants made to institutions** 

|**13.2 Grants made to institutions**|**13.2 Grants made to institutions**|||
|---|---|---|---|
|**_My charity has made grants to particular institutions that are material in_**<br>**_the context of its grantmaking.  Details of the institution supported,_**<br>**_purpose of the grant and total paid to each institution is available on the_**<br>**_charity's web site._**||**_Yes_**|**_Please provide_**<br>**_details of charity's_**<br>**_URL._**|
|||**_No_**|**_Provide details_**<br>**_below_**|
|||||
|**Names of institution**|**Purpose**||**Total amount of**<br>**grants paid £**|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
||||-|
|**_TOTAL GRANTS PAID_**<br>**_Other unanalysed grants_**<br>**_Total grants to institutions in reporting period_**|||**-**|
||||-|
||||-|



CC17a (Excel) 

10/07/2025 

20 



**Section C                                            Notes to the accounts                                         (cont)** 

**Note 14                           Tangible fixed assets** _**Please complete this note if the charity has any tangible fixed assets**_ 

## **14.1 Cost or valuation** 

|**14.1 Cost or valuation**|**n**||||||
|---|---|---|---|---|---|---|
|**Freehold land**<br>**& buildings**<br>**Other land &**<br>**buildings**<br>**£**<br>**£**<br>At the beginning of<br>the year<br>-                      -<br>Additions<br>-                      -<br>Revaluations<br>-                      -<br>Disposals<br>-                      -<br>Transfers *<br>-                      -<br>At end of the year<br>-                      -<br>****Basis**<br>SL or RB<br>SL or RB<br>**** Rate**<br>At beginning of the<br>year<br>-                      -<br>Disposals<br>-                      -<br>Depreciation<br>-                      -<br>Impairment<br>-                      -<br>Transfers*<br>-                      -<br>At end of the year<br>-                      -<br>Net book value at the<br>beginning of the year<br>-                      -<br>Net book value at the<br>end of the year<br>-                      -<br>**14.4  Impairment**<br>**14.3 Net book value**<br>**14.2 Depreciation and impairments**<br>**_Please provide a description of the events and_**<br>**_circumstances that led to the recognition or_**<br>**_reversal of an impairment loss._**|**Freehold land**<br>**& buildings**<br>**£**|**Other land &**<br>**buildings**<br>**£**|**Plant,**<br>**machinery and**<br>**motor**<br>**vehicles**<br>**£**|<br>**Fixtures,**<br>**fittings and**<br>**equipment**<br>**£**|**Total**<br>**£**||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||**d impairments**||||||
||SL or RB|SL or RB|SL or RB|SL or RB|SL or RB|Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")|
||||||||
||||-                      -                      -<br>-                      -                      -<br>-                      -                      -<br>-                      -                      -<br>-                      -                      -<br>-                      -                      -<br>-                      -                      -<br>-                      -                      -||||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||-|-|-|-|-||
||||||||
||-|-|-|-|-||
||-|-|-|-|-||
||||||||



**14.5  Revaluation** _**If an accounting policy of revaluation is adopted, please provide: the effective date of the revaluation the name of independent valuer, if applicable the methods applied and significant assumptions the carrying amount that would have been recognised had the assets been carried under the cost model.**_ 

**14.6  Other disclosures** _**(i)   Please state the amount of borrowing costs, if any, capitalised in the construction of tangible fixed assets and the capitalisation rate used. (ii)   Please provide the amount of contractual commitments for the acquisition of tangible fixed assets. (iii)   Details of the existence and carrying amounts of property, plant and equipment to which the charity has restricted title or that are pledged as security for liabilities.**_ 

- _The "transfers" row is for movements between fixed asset categories._ 

- _** Please indicate the method of depreciation by deleting the method not applicable (SL = straight_ 

CC17a (Excel) 

10/07/2025 

21 



## **Section C                                            Notes to the accounts** 

## **Note 15                          Intangible assets** _**Please complete this note if the charity has any intangible assets**_ **15.1 Cost or valuation** 

|**Research &**<br>**development**<br>**Patents and**<br>**trademarks**<br>**Other**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Additions<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Revaluations<br>-                     -                     -                     -<br>Transfers *<br>-                     -                     -                     -<br>At end of the year<br>-                     -                     -                     -<br>****Basis**<br>SL or RB<br>SL or RB<br>SL or RB<br>SL or RB<br>Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")<br>**** Rate**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Amortisation<br>-                     -                     -                     -<br>Impairment<br>-                     -                     -                     -<br>Transfers*<br>-                     -                     -                     -<br>At end of year<br>-                     -                     -                     -<br>Nat book value at the<br>beginning of the year<br>-                     -                     -                     -<br>Net book value at the<br>end of the year<br>-                     -                     -                     -<br>**15.2 Amortisation and impairments**<br>**15.3 Net book value**|**Research &**<br>**development**<br>**Patents and**<br>**trademarks**<br>**Other**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Additions<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Revaluations<br>-                     -                     -                     -<br>Transfers *<br>-                     -                     -                     -<br>At end of the year<br>-                     -                     -                     -<br>****Basis**<br>SL or RB<br>SL or RB<br>SL or RB<br>SL or RB<br>Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")<br>**** Rate**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Amortisation<br>-                     -                     -                     -<br>Impairment<br>-                     -                     -                     -<br>Transfers*<br>-                     -                     -                     -<br>At end of year<br>-                     -                     -                     -<br>Nat book value at the<br>beginning of the year<br>-                     -                     -                     -<br>Net book value at the<br>end of the year<br>-                     -                     -                     -<br>**15.2 Amortisation and impairments**<br>**15.3 Net book value**|**Research &**<br>**development**<br>**Patents and**<br>**trademarks**<br>**Other**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Additions<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Revaluations<br>-                     -                     -                     -<br>Transfers *<br>-                     -                     -                     -<br>At end of the year<br>-                     -                     -                     -<br>****Basis**<br>SL or RB<br>SL or RB<br>SL or RB<br>SL or RB<br>Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")<br>**** Rate**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Amortisation<br>-                     -                     -                     -<br>Impairment<br>-                     -                     -                     -<br>Transfers*<br>-                     -                     -                     -<br>At end of year<br>-                     -                     -                     -<br>Nat book value at the<br>beginning of the year<br>-                     -                     -                     -<br>Net book value at the<br>end of the year<br>-                     -                     -                     -<br>**15.2 Amortisation and impairments**<br>**15.3 Net book value**|**Research &**<br>**development**<br>**Patents and**<br>**trademarks**<br>**Other**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Additions<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Revaluations<br>-                     -                     -                     -<br>Transfers *<br>-                     -                     -                     -<br>At end of the year<br>-                     -                     -                     -<br>****Basis**<br>SL or RB<br>SL or RB<br>SL or RB<br>SL or RB<br>Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")<br>**** Rate**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Amortisation<br>-                     -                     -                     -<br>Impairment<br>-                     -                     -                     -<br>Transfers*<br>-                     -                     -                     -<br>At end of year<br>-                     -                     -                     -<br>Nat book value at the<br>beginning of the year<br>-                     -                     -                     -<br>Net book value at the<br>end of the year<br>-                     -                     -                     -<br>**15.2 Amortisation and impairments**<br>**15.3 Net book value**|**Research &**<br>**development**<br>**Patents and**<br>**trademarks**<br>**Other**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Additions<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Revaluations<br>-                     -                     -                     -<br>Transfers *<br>-                     -                     -                     -<br>At end of the year<br>-                     -                     -                     -<br>****Basis**<br>SL or RB<br>SL or RB<br>SL or RB<br>SL or RB<br>Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")<br>**** Rate**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Amortisation<br>-                     -                     -                     -<br>Impairment<br>-                     -                     -                     -<br>Transfers*<br>-                     -                     -                     -<br>At end of year<br>-                     -                     -                     -<br>Nat book value at the<br>beginning of the year<br>-                     -                     -                     -<br>Net book value at the<br>end of the year<br>-                     -                     -                     -<br>**15.2 Amortisation and impairments**<br>**15.3 Net book value**|**Research &**<br>**development**<br>**Patents and**<br>**trademarks**<br>**Other**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Additions<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Revaluations<br>-                     -                     -                     -<br>Transfers *<br>-                     -                     -                     -<br>At end of the year<br>-                     -                     -                     -<br>****Basis**<br>SL or RB<br>SL or RB<br>SL or RB<br>SL or RB<br>Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")<br>**** Rate**<br>At beginning of the<br>year<br>-                     -                     -                     -<br>Disposals<br>-                     -                     -                     -<br>Amortisation<br>-                     -                     -                     -<br>Impairment<br>-                     -                     -                     -<br>Transfers*<br>-                     -                     -                     -<br>At end of year<br>-                     -                     -                     -<br>Nat book value at the<br>beginning of the year<br>-                     -                     -                     -<br>Net book value at the<br>end of the year<br>-                     -                     -                     -<br>**15.2 Amortisation and impairments**<br>**15.3 Net book value**|
|---|---|---|---|---|---|
||SL or RB|SL or RB|SL or RB|SL or RB|Straight Line<br>("SL") or<br>Reducing<br>Balance<br>("RB")|
|||||||
||-                     -                     -                     -<br>-                     -                     -                     -<br>-                     -                     -                     -<br>-                     -                     -                     -<br>-                     -                     -                     -<br>-                     -                     -                     -<br>-                     -                     -                     -<br>-                     -                     -                     -|||||
||-|-|-|-||
||-|-|-|-||



## **15.4 Accounting policy** _**Please disclose the accounting policy for intangible fixed assets including: Reasons for choosing amortisation rates**_ 

CC17a (Excel) 

10/07/2025 

22 



_**Policies for the recognition of any capital development**_ 

## **15.5 Impairment** 

_**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ 

## **15.6 Revaluation** 

_**If an accounting policy of revaluation is adopted, please provide:**_ 

_**the effective date of the revaluation**_ 

_**the name of independent valuer, if applicable**_ 

_**the methods applied**_ 

_**the carrying amount that would have been recognised had the assets been carried under the cost model.**_ 

## **15.7 Other disclosures** 

_**(i)   If your intangible asset was acquired by way of grant, provide value on initial recognition and carrying amount of the asset.**_ 

_**(ii)     Details of the carrying amounts of any intangible assets to which the charity has restricted title or that are pledged as security for liabilities.**_ 

_**(iii)   Please provide the amount of contractual commitments for the acquisition of intangible assets.**_ 

_**(iv)  State the amount of research and development expenditure recognised as expenditure in the year.**_ 

_**(vi)   Please detail the headings in the SOFA in which a charge for amortisation of intangible assets is included.**_ 

_**(vii)   For any material intangible assets, please provide a description, its carrying amount and any remaining amortisation period.**_ 

_*  The "transfers" row is for movements between fixed asset categories._ 

_** Please indicate the method of depreciation by deleting the method not applicable (SL = straight line; RB = reducing balance). Also please indicate the rate of depreciation: for straight line, what is the anticipated life of the asset (in years); for reducing balance, what is the percentage annual_ 

CC17a (Excel) 

10/07/2025 

23 



## **Section C                                            Notes to the accounts                                                  (cont)** 

**Note 16                           Heritage assets** _**Please complete this note if the charity has heritage assets**_ 

## **16.1 General disclosures for all charities holding heritage assets** 

**(i)   Explain the nature and scale of heritage assets held. (ii)   Explain the policy for the acquisition, preservation, management and disposal of heritage assets.** 

|At beginning of the year<br>Additions<br>Disposals<br>Revaluations<br>Transfers *<br>At end of the year<br>****Basis**<br>**** Rate**<br>At beginning of the year<br>Disposals<br>Depreciation<br>Impairment<br>Transfers*<br>At end of year<br>Nat book value at the beginning of the<br>year<br>Net book value at the end of the year<br>**16.5 Impairment**<br>**16.3 Depreciation and impairments**<br>**16.4 Net book value**<br>**16.2 Cost or valuation**|**Heritage asset**<br>**1**<br>**Heritage asset**<br>**2**<br>**Heritage asset**<br>**3**<br>**Heritage asset**<br>**4**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -|**Heritage asset**<br>**1**<br>**Heritage asset**<br>**2**<br>**Heritage asset**<br>**3**<br>**Heritage asset**<br>**4**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -|**Heritage asset**<br>**1**<br>**Heritage asset**<br>**2**<br>**Heritage asset**<br>**3**<br>**Heritage asset**<br>**4**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -|**Heritage asset**<br>**1**<br>**Heritage asset**<br>**2**<br>**Heritage asset**<br>**3**<br>**Heritage asset**<br>**4**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -|**Heritage asset**<br>**1**<br>**Heritage asset**<br>**2**<br>**Heritage asset**<br>**3**<br>**Heritage asset**<br>**4**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -|**Heritage asset**<br>**1**<br>**Heritage asset**<br>**2**<br>**Heritage asset**<br>**3**<br>**Heritage asset**<br>**4**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -|
|---|---|---|---|---|---|---|
|||||||Straight Line<br>("SL") or<br>Reducing<br>Balance|
||||||||
||-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -<br>-                     -                     -                     -                     -||||||



_**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ 

**16.6 Revaluation** _**If an accounting policy of revaluation is adopted, please provide: the effective date of the revaluation the name of independent valuer, if applicable qualifications of independent valuer the methods applied and significant assumptions any significant limitations on the valuation**_ 

**16.7 Analysis of heritage assets by class or group distinguishing those at cost and those at valuation** 

CC17a (Excel) 

10/07/2025 

24 



|Carrying amount at the beginning of the<br>period<br>Additions<br>Disposals<br>Depreciation/impairment<br>Revaluation<br>Carrying amount at the end of period|**At valuation**<br>**Group A**<br>**£**|**At cost Group**<br>**B**<br>**£**|**Total**<br>**£**|
|---|---|---|---|
||-|-|-|
||-|-|-|
||-|-|-|
||-|-|-|
||-|-|-|
||-|-|-|



## **16.8 Heritage assets (where heritage assets are not recoignised on the balance sheet)** 

**(i)   Explain the reason why heritage assets have not been recognised on the balance sheet. (ii)   Describe the significance and nature of heritage assets. (iii)   Disclose information that is helpful in assessing the value of heritage assets. (iv)   Explain the reason why it is not practicable to obtain a valuation of heritage assets.** 

## **16.9 Five year summary of heritage assets transactions** 

||**2015**|**2014**|**2013**|**2012**|**2011**|
|---|---|---|---|---|---|
||**£**|**£**|**£**|**£**|**£**|
|**Purchases**<br>Group A<br>Group B<br>Group C<br>Other<br>**Donations**<br>Group A<br>Group B<br>Group C<br>Other<br>**Total additions**<br>**Charge for impairment**<br>Group A<br>Group B<br>Group C<br>Other<br>**Total charge for impairment**<br>**Disposals**<br>Group A - carrying amount<br>Group B - carrying amount<br>Group C<br>Other<br>**Total disposals**||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|||||
||-|||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|



CC17a (Excel) 

10/07/2025 

25 



## **Section C                                            Notes to the accounts                                                        (cont)** 

**Note 17                         Investment assets** 

_**Please complete this note if the charity has any investment assets.**_ 

## **17.1 Fixed assets investments (please provide for each class of investment)** 

|Carrying (fair) value at beginning of<br>period<br>**Add:**additions to investments during<br>period*<br>**Less:**disposals at carrying value<br>**Less: impairments**<br>**Add: Reversal of impairments**<br>**Add/(deduct):**transfer in/(out) in the<br>period<br>**Add/(deduct):**net gain/(loss) on<br>revaluation<br>Carrying (fair) value at end of year|**Cash & cash**<br>**equivalents**|<br>**Listed**<br>**investments**|**Investment**<br>**properties**|**Social**<br>**investments**|**Other**|**Total**|
|---|---|---|---|---|---|---|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|
||-|-|-|-|-|-|



***Please specify additions resulting from acquisitions through business combinations, if any.** 

_**Please note that Fair Value in this context is the amount for which an asset could be exchanged between knowlegable and willing parties in an arm's length transaction.  For traded securities, the fair value is the value of the security quoted on the London Stock Exchange Daily Official List or equivalent.  For other assets where there is no market price on a traded market, it is the trustees' or valuers' best estimate of fair value.**_ 

**17.2  Please provide a breakdown of investments shown above agreeing with the balance sheet row B04 differentiating between those held at fair value and those held at cost less impairment.** 

|**Analysis of investments**<br>**Cash or cash equivalents**<br>**Investment properties**<br>**Other investments**<br>**Total**<br>**Social investments**<br>**Grand total (Fair value at year end+Cost less impairment)**<br>**Listed investments**||||
|---|---|---|---|
||**Fair value at year end**|**Cost less impairment**||
||**£**|**£**||
||-|-||
||-|-||
||-|-||
||-|-||
||-|-||
||-|-||
|||||



## **17.3 If your charity holds investment properties, please complete the following note:** 

**(i)   Explain the methods and significant assumptions in determining the fair value of investment property held by the charity (ii)   Name or independent valuer, if applicable, and relevant qualifications (iii)   Provide details of any restrictions on the ability to realise investment property or on the remittance of income or disposal proceeds (iv)   Explain any contractual obligations for the purchase, construction or development of investment property or for repairs, maintenance or enhancements** 

CC17a (Excel) 

10/07/2025 

26 



## **17.4  Please provide a breakdown of current asset investments, if applicable, agreeing with the balance sheet.** 

|**Analysis of current asset**<br>**investments**<br>**Cash or cash equivalents**<br>**Investment properties**<br>**Amount of concessionary loans received**<br>**_(Multiple loans received may be disclosed in_**<br>**_aggregate provided that such aggregation does not_**<br>**_obsure significant information)._**<br>**For all investments measured at fair value, the**<br>**basis for determining the value, including any**<br>**assumptions applied when using a valuation**<br>**technique.**<br>**17.7 Additional information**<br>**Please provide information about the**<br>**significance of investments to the charity's**<br>**financial position or performance eg. terms and**<br>**conditions of loans or the use of hedging to**<br>**manage financial risk.**<br>**Amounts receivable after more than 1 year**<br>**Amounts payable after more than 1 year**<br>**Amounts receivable within 1 year**<br>**Where a charity has provided financial assets as**<br>**a form of security, the carrying amount of the**<br>**financial asset pledged as security and the terms**<br>**and conditions relating to its pledge.**<br>**Terms and conditions eg interest rate, security**<br>**provided**<br>**Value of any concessionary loans which have**<br>**been committed but not taken up at the reporting**<br>**date**<br>**Amounts payable within 1 year**<br>**Social investments**<br>**17.5 Guarantees**<br>**Listed investments**<br>**Please provide details and amount of any**<br>**guarantee made to or on behalf of a third party**<br>**Name of the entity or entities benefitting from**<br>**those guarantees**<br>**Please explain how the guarantee furthers the**<br>**charity's aims**<br>**17.6 Concessionary loans**<br>**Amount of concessionary loans made (****_Multiple_**<br>**_loans made may be disclosed in aggregate provided_**<br>**_that such aggregation does not obsure significant_**<br>**_information_ ).**<br>**Other investments**<br>**Total**||**This year**|**Las**|**t year**|**t year**|
|---|---|---|---|---|---|
|||**£**||**£**||
|||-||-||
|||-||-||
|||-||-||
|||-||-||
|||-||-||
|||-||-||
|||||||
|||||||
|||||||
|||||||
|||||||
|||**_Description_**||**This year £**|**Last year £**|
|||||||
|||||||
|||||||
|||||||
||**_Total_**|||||
|||||||
|||**_Description_**||**This year £**|**Last year £**|
|||||||
|||||||
|||||||
||**_Total_**|||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||



CC17a (Excel) 

10/07/2025 

27 



## **Section C                                     Notes to the accounts                                  (cont)** 

## **Note 18                         Stocks** 

## _**Please complete this note if the charity holds any stock items**_ 

## **18.1  Please state the carrying amount of stock and work in progress analysed between activities.** 

|**For**<br>**distribution**<br>**For resale**<br>**For**<br>**distribution**<br>**For resale**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**Charitable activities:**<br>**_Opening_**<br>-                  -                   -               -                 -<br>**_Added in period_**<br>-                  -                   -               -                 -<br>**_Expensed in period_**<br>-                  -                   -               -                 -<br>**_Impaired_**<br>-                  -                   -               -                 -<br>**_Closing_**<br>**-                  -                   -               -                 -**<br>**Other trading activities:**<br>**_Opening_**<br>-                  -                   -               -                 -<br>**_Added in period_**<br>-                  -                   -               -                 -<br>**_Expensed in period_**<br>-                  -                   -               -                 -<br>**_Impaired_**<br>-                  -                   -               -                 -<br>**_Closing_**<br>**-                  -                   -               -                 -**<br>**Other:**<br>**_Opening_**<br>-                  -                   -               -                 -<br>**_Added in period_**<br>-                  -                   -               -                 -<br>**_Expensed in period_**<br>-                  -                   -               -                 -<br>**_Impaired_**<br>-                  -                   -               -                 -<br>**_Closing_**<br>**-                  -                   -               -                 -**<br>**Total this year**<br>-                  -                   -               -                 -<br>**_Total previous year_**<br>-                  -                   -               -                 -<br>**Work in**<br>**progress**<br>**18.2   Please specify the carrying amount of**<br>**any stocks pledged as security for liabilities**<br>**Stock**<br>**Donated goods**|**Stock**|**Stock**|**Donated goods**|**Donated goods**|**Work in**<br>**progress**|
|---|---|---|---|---|---|
||**For**<br>**distribution**|**For resale**|**For**<br>**distribution**|**For resale**||
||**£**|**£**|**£**|**£**|**£**|
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
|||||||
|||||||
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||-|-|-|-|-|
||**-**|**-**|**-**|**-**|**-**|
||-|-|-|-|-|
||-|-|-|-|-|
|||||||
|||||||



CC17a (Excel) 

10/07/2025 

28 



## **Section C                                            Notes to the accounts                                               (cont)** 

## **Note 19                         Debtors and prepayments** 

_**Please complete this note if the charity has any debtors or prepayments.**_ 

## **19.1     Analysis of debtors** 

|**Trade debtors**<br>**Prepayments and accrued income**<br>**Other debtors**<br>**Total**|**This year**<br>**£**|**Last year**<br>**£**|
|---|---|---|
||-|-|
||6,660|5,330|
||14,405|51,180|
||21,065|56,510|



## _**Please complete 19.2 where a material debtor is recoverable more than a year after the reporting date.**_ 

## **19.2     Analysis of debtors recoverable in more than 1 year (included in debtors above)** 

|**Trade debtors**<br>**Prepayments and accrued income**<br>**Other debtors**<br>**Total**|**This year**<br>**£**|**Last year**<br>**£**|
|---|---|---|
||-|-|
||-|-|
||-|-|
||-|-|
||-|-|



CC17a (Excel) 

10/07/2025 

29 



## **Section C                                          Notes to the accounts                                                   (cont)** 

## **Note 20                         Creditors and accruals** 

## _**Please complete this note if the charity has any creditors or accruals.**_ 

## **20.1 Analysis of creditors** 

|**Accruals for grants payable**<br>**Bank loans and overdrafts**<br>**Trade creditors**<br>**Payments received on account for contracts or**<br>**performance-related grants**<br>**Accruals and deferred income**<br>**Taxation and social security**<br>**Other creditors**<br>**Total**|**Amounts falling due**<br>**within oneyear**|**Amounts falling due**<br>**within oneyear**|**Amounts falling due after**<br>**more than oneyear**|**Amounts falling due after**<br>**more than oneyear**|
|---|---|---|---|---|
||**This year**<br>**£**|**Last year**<br>**£**|**This year**<br>**£**|**Last year**<br>**£**|
||-|-|-|-|
||-|-|-|-|
||-|-|-|-|
||-|-|-|-|
||3,640|3,050|-|-|
||-|-|-|-|
||10,438|49,019|-|-|
||14,078|52,069|-|-|



## **20.2 Deferred income** 

## _**Please complete this note if the charity has deferred income.**_ 

## _**Please explain the reasons why income is deferred.**_ 

_There was no deferred income as at 31 December 2024 and 31 December 2023._ 

|**_Movement in deferred income account_**<br>**Balance at the start of the reporting period**<br>**Amounts added in current period**<br>**Amounts released to income from previous periods**<br>**Balance at the end of the reporting period**|**This year**<br>**£**|**Last year**<br>**£**|
|---|---|---|
||-|<br>20,705|
||-|-|
||-|<br>(20,705)|
||-|<br>0|



CC17a (Excel) 

10/07/2025 

30 



## **Section C                                            Notes to the accounts                                               (cont)** 

## **Note 21  Provisions for liabilities and charges** 

_**Please complete this note if you have included in charity expenditure any provisions.  A provision is made when the charity has a liability of uncertain timing or amount.**_ 

## **21.1  Please provide:** 

**- a brief description of any obligations on the balance sheet and the expected amount and timing of resulting payments; - an indication of the uncertainties about the amount or timing of those outflows; and - the amount of any expected reimbursement, stating the amount of any asset that has been recognised for that expected reimbursement.** 

## **21.2  Movements in recognised provisions and funding commitment during the period** 

|**Balance at the start of the reporting period**<br>**Amounts added in current period**<br>**Amounts charged against the provision in the current period**<br>**Unused amounts reversed during the period**<br>**Balance at the end of the reporting period**|**This year**<br>**£**|**Last year**<br>**£**|
|---|---|---|
||-|-|
||-|-|
||-|-|
||-|-|
||-|-|



**21.3  For any funding commitment that is not recognised as a liability or provision, provide details of commitment made, the time frame of that commitment, any performance-related conditions and details of how the commitment will be funded (with contracts for capital expenditure separately identified).** 

**21.4  Where unrestricted funds have been designated to a fund commitment, please disclose the nature of any amounts designated and the likely timing of that expenditure.** 

CC17a (Excel) 

10/07/2025 

31 



**Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 22   Other disclosures for debtors, creditors and other basic financial instruments** 

**22.1  Please provide information about the** The charity’s principal financial instruments comprise **significance of financial instruments (eg. debtors,** cash, other debtors and other creditors, the main **creditors, investments etc) to the charity's financial** purpose of which is to finance the charity’s operations **position or performance, for example, the terms and** and activities. **conditions of loans or the use of hedging to manage financial risk.** The charity does not acquire put options, derivatives or other complex financial instruments. **22.1  If the charity has provided financial assets as a** Not applicable **form of security, the carrying amount of the financial assets pledged as security and the terms and conitions related to its pledge should be given here.** 

CC17a (Excel) 

10/07/2025 

32 



## **Section C                                            Notes to the accounts                                                 (cont)** 

## **Note 23  Contingent liabilities and contingent assets** 

## **23.1  Contingent liabilities** 

**Where the charity has contingent liabililities, please complete the following section unless the possibility of their existence is remote.** 

**Description of item including its legal nature.  Please Estimate of financial effect describe any security provided in connection to the liability.** 

## **23.2  Contingent assets** 

## **Where the charity has contingent assets, please complete the following section when their existence is probable** 

**Description of item Estimate of financial effect** 

**23.4  Other disclosures for contingent assets and/or liabilities Please provide the following information where practicable:** 

**Explain any uncertainties relating to the amount or timing of settlement; and the possibilty of any reimbursement** 

**Where it is not practical to make one or more of these disclosures, please state this fact** 

CC17a (Excel) 

10/07/2025 

33 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 24                     Cash at bank and in hand** 

|**Note 24                     Cash at bank and in hand**|||
|---|---|---|
|**Other**<br>**Cash at bank and on hand**<br>**Total**<br>**Short term cash investments (less than 3 months maturity date)**<br>**Short term deposits**|**This year**<br>**£**|**Last year**<br>**£**|
||-|-|
||-|-|
||130,906|126,382|
||-|-|
||130,906|126,382|



CC17a (Excel) 

10/07/2025 

34 



## **Section C                                            Notes to the accounts                                          (cont)** 

## **Note 25             Fair value of assets and liabilities** 

The main risks arising from the charity’s financial instruments are credit risk and liquidity risk. The trustees review and agree policies for managing each of these risks and these are summarised below. 

**25.1  Please provide details of the charity's exposure to credit risk (the risk of incurring a loss due to a debtor not paying what is owed) , liquidity risk (the risk of not being able to meet short term financial demands) and market risk (the risk that the value of an investment will fall due to changes in the market) arising from financial instruments to which the charity is exposed at the end of the reporting period and explain how the charity manages those risks.** 

## Credit risk 

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the charity, and arises principally from the debtors balance at the year-end, which are considered by the trustees to be recoverable. 

## Liquidity risk 

The charity’s policy throughout the year has been to ensure that it has adequate liquidity by careful management of its working capital. 

**25.2  Please give details of the amount of change in the fair value of basic financial instruments (debtors, creditors, investments (see section 11, FRS 102 SORP)) measured at fair value through the SoFA that is attributable to changes in credit risk.** 

Not applicable 

CC17a (Excel) 

10/07/2025 

35 



**Section C                                       Notes to the accounts                                      (cont)** 

**Note 26                         Events after the end of the reporting period** _**Please complete this note events (not requiring adjustment to the accounts) have occurred after the end of the reporting period but before the accounts are authorised which relate to conditions that arose after the end of the reporting period.**_ 

**Please provide details of the nature of the event** 

**Provide an estimate of the financial effect of the event or a statement that such an estimate cannot be made** 

None Not applicable 

CC17a (Excel) 

10/07/2025 

36 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 27                         Charity funds** 

## **27.1 Details of material funds held and movements during the CURRENT reporting period** 

_**Please give details of the movements of material individual funds in the reporting period together with a balancing figure for 'Other funds'.  The 'Total funds' figure below should reconcile to 'Total funds' in the blanace sheet.**_ 

_*** Key: PE - permanent endowment funds; EE - expendible endowment funds; R - restricted income funds, including special trusts, of the charity; and U - unrestricted funds**_ 

|**_funds_**|||||||||
|---|---|---|---|---|---|---|---|---|
|**Fund names**|**Type PE, EE**<br>**R or UR ***|<br>**Purpose and Restrictions**|**Fund**<br>**balances**<br>**brought**<br>**forward**<br>**£**|**Income**<br>**£**|**Expenditure**<br>**£**|**Transfers**<br>**£**|**Gains and**<br>**losses**<br>**£**|**Fund**<br>**balances**<br>**carried**<br>**forward**<br>**£**|
|Unrestricted funds|UR|Not applicable|130,823|230,900|(223,830)|-|-|137,893|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
|**_Other funds_**|**N/a**|**N/a**|-|-|-|-|-|-|
|**Total Funds**|||130,823|230,900|(223,830)|-|-|137,893|



CC17a (Excel) 

10/07/2025 

37 



## **Section C                                            Notes to the accounts                                                        (cont)** 

**Note 27                         Charity funds (cont)** 

## **27.2 Details of material funds held and movements during the PREVIOUS reporting period** 

_**Please give details of the movements of material individual funds in the reporting period together with a balancing figure for 'Other funds'.  The 'Total funds' figure below should reconcile to 'Total funds' in the blanace sheet.**_ 

_*** Key: PE - permanent endowment funds; EE - expendible endowment funds; R - restricted income funds, including special trusts, of the charity; and U - unrestricted funds**_ 

|**_funds_**|||||||||
|---|---|---|---|---|---|---|---|---|
|**Fund names**|**Type PE, EE**<br>**R or UR ***|<br>**Purpose and Restrictions**|**Fund**<br>**balances**<br>**brought**<br>**forward**<br>**£**|**Income**<br>**£**|**Expenditure**<br>**£**|**Transfers**<br>**£**|**Gains and**<br>**losses**<br>**£**|**Fund**<br>**balances**<br>**carried**<br>**forward**<br>**£**|
|Unrestrictedfunds|UR|Not applicable|175,542|296,886|(341,605)|-|-|130,823|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
||||-|-|-|-|-|-|
|**_Other funds_**|**N/a**|**N/a**|-|-|-|-|-|-|
|**Total Funds**|||175,542<br>|296,886|(341,605)|-|-|130,823|



CC17a (Excel) 

10/07/2025 

38 



**Section C                                            Notes to the accounts                                                 (cont)** 

## **Note 27                         Charity funds (cont)** 

## **27.3  Transfers between funds** 

||**Reason for transfer and where endowment is converted to**<br>**income, legal power for its conversion**|**Amount**|
|---|---|---|
|Between unrestricted and<br>restricted funds|||
|Between endowment and<br>restricted funds|||
|Between endowment and<br>unrestricted funds|||
||||



## **27.4 Designated funds** 

**Planned use Purpose of the designation Amount** 

CC17a (Excel) 

10/07/2025 

39 



## **Section C                                            Notes to the accounts                                                        (cont)** 

## **Note 28                         Transactions with trustees and related parties** 

_**If the charity has any transactions with related parties (other than the trustee expenses explained in guidance notes) details of such transactions should be provided in this note.  If there are no transactions to report, please enter “True” in the box or "False" if there are transactions to report.**_ 

## **28.1 Trustee remuneration and benefits** 

**None of the trustees have been paid any remuneration or received any other benefits from an employment with their charity or a related entity (True or False)** 

**TRUE** 

_**In the period the charity has paid trustees remuneration and benefits.  Please give the amount of, and legal authority for, any remuneration or other benefits paid to a trustee by the charity or any institution or company connected with it.**_ 

|**Name of trustee**|**Legal authority (eg**<br>**order, governing**<br>**document)**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|
|---|---|---|---|---|---|---|
|||**This year**||||**Last year**|
|||**Remuneration**|**Pension**<br>**contribution**<br>|**Redundancy**<br>**(including**<br>**loss of**<br>**office)/ex**<br>~~**gratia**~~<br>|**Other**|<br>**TOTAL**|
|||**£**|**£**||**£**|**£**|
||||||||



_**Please give details of why remuneration or other employment benefits were paid.**_ 

_**Where an ex gratia payment has been made to a trustee, provide an explanation of the nature of the payment.**_ 

## **28.2 Trustees' expenses** 

_**If the charity has paid trustees expenses for fulfilling their duties, details of such transactions should be provided in this note.  If there are no transactions to report, please enter “True” in the box below. If there are transactions to report, please enter "False".**_ 

|**No trustee expenses have been incurred (True or False)**||**_TRUE_**|
|---|---|---|
||||
|**Type of expenses reimbursed**|**This year**|**Last year**|
||**£**|**£**|
|**Travel**|||
|**Subsistence**|||
|**Accommodation**|||
|**Other (please specify):**|||
||||
|**TOTAL**|||



**Please provide the number of trustees reimbursed for expenses or who had expenses paid by the charity** 

## **28.3 Transaction(s) with related parties** 

_**Please give details of any transaction undertaken by (or on behalf of) the charity in which a related party has a material interest, including where funds have been held as agent for related parties.  If there are no such transactions, please enter 'true' in the box provided.**_ 

**There have been no related party transactions in the reporting period (True or False)** 

|||||||||
|---|---|---|---|---|---|---|---|
|**There have been no related party transactions in the reporting period (True or False)**||||||**_TRUE_**||
|||||||||
|**Name of the trustee**<br>**or related party**|**Relationship**<br>**to charity**|**Description of the**<br>**transaction(s)**|**Amount**|**Balance at**<br>**period end**|**Provision for bad**<br>**debts at period end**||**Amounts**<br>**written off**<br>**during**<br>**reporting**<br>**period**|
||||**£**|**£**|**£**||**£**|
|||||||||
|**_In relation to the transactions above, please provide the_**<br>**_terms and conditions, including any security and the nature_**<br>**_of any payment (consideration) to be provided in_**<br>**_settlement._**||||||||
|||||||||



_**For any related party, please provide details of any guarantees given or received.**_ 

CC17a (Excel) 

10/07/2025 

40 



**Section C                                            Notes to the accounts                                   (cont)** 

## **Note 29                            Additional Disclosures** 

**The following are significant matters which are not covered in other notes and need to be included to provide a proper understanding of the accounts.  If there is insufficient room here, please add a separate sheet.** 

None 

CC17a (Excel) 

10/07/2025 

41 



## **Independent examiner's report on the accounts** 

**Section A                        Independent Examiner’s Report** 

**Report to the trustees/ members of** The British Uro-Oncology Group 

|**On accounts for the year**|31 December 2024|**Charity no**|1116828|
|---|---|---|---|
|**ended**||**(if any)**||
|||||
|**Set out on pages**|Page 1 to 41|||



I report to the trustees on my examination of the accounts of the above charity for the year ended 31 December 2024. 

**Responsibilities and** As the charity's trustees, you are responsible for the preparation of the **basis of report** accounts in accordance with the requirements of the Charities Act 2011 (“the Act”). 

I report in respect of my examination of the charity’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 

**Independent** I am qualified to undertake the examination by being a qualified member of **examiner's statement** the Association of Chartered Certified Accountants. 

I have completed my examination.  I confirm that no material matters have come to my attention in connection with the examination which gives me cause to believe that in, any material respect: 

- the accounting records were not kept in accordance with section 130 of the Charities Act; or 

- the accounts did not accord with the accounting records; or 

- the accounts did not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair’ view which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached, except for those stated in Section B. 

**Signed: Date:** 29.09.2025 **Name:** Keeley Edwards **Relevant professional** FCCA **qualification(s) or body (if any):** 

1 

**Oct 2018** 

**IER** 



Sawin & Edwards LLP, Studio 16, Cloisters House, 8 Battersea Park Road, **Address:** London, SW8 4BG 

## **Section B                           Disclosure** 

Only complete if the examiner needs to highlight material matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners). 

**Give here brief details of** None **any items that the examiner wishes to disclose** . 

2 

**Oct 2018** 

**IER** 

